Search Results

You are looking at 281 - 290 of 578 items for :

  • Refine by Access: All x
Clear All
Full access

Updates in the Management of Small Cell Lung Cancer

Presented by: Apar Kishor Ganti

-up.” Although PCI decreases the incidence of brain metastases, it is associated with toxicities. Acute toxicities include scalp edema, fatigue, alopecia, nausea, and vomiting; long-term toxicities such as neurologic and intellectual disabilities become more

Full access

Management of Renal Cell Carcinoma

Presented by: Michael Serzan

nivolumab/ipilimumab. However, patients treated with IO/TKIs tend to experience more chronic TKI toxicities, such as fatigue, hypertension, and diarrhea, that are typically managed with dose reduction or holding VEGF TKI. Although these IO/TKI regimens have

Full access

Emerging Therapies in the Treatment of Bladder Cancer

Presented by: Arlene O. Siefker-Radtke

clinical benefits, patients treated with enfortumab vedotin + pembrolizumab may still experience toxicities. Neuropathy, fatigue, and alopecia, as well as enfortumab vedotin–associated side effects, such as Stevens-Johnson syndrome, peeling of the skin

Full access

NCCN News

consensus. Drs. Llor and Ness both stressed that patients at any age who experience symptoms should be evaluated for CRC. Some of those symptoms include: rectal bleeding, changes in bowel habits, persistent stomach pain, fatigue, and unexplained

Full access

NCCN News

that it’s done,” explained Crystal Denlinger, MD, Fox Chase Cancer Center, Chair of the NCCN Guidelines Panel for Survivorship. “Treatment may end, but fatigue, neuropathy, and other effects can linger. For some, cancer survivorship means long

Full access

Management of Metastatic Prostate Cancer

Presented by: Archana Ajmera, Rana R. McKay, and Kelly L. Stratton

177 Lu-PSMA-617 improved both the objective response rate and PSA responses. “I think [one of] the biggest things to watch out for with this regimen are fatigue and myelosuppression,” she remarked. Dry mouth, nausea and vomiting, and renal effects were

Full access

Optimizing Treatment for Head and Neck Cancers: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Presented by: Robert I. Haddad

amount of pain and fatigue, as well as difficulty eating and swallowing. Many are feeding tube–dependent and are unable to socialize, go to work, or maintain intimacy and sexuality. A large number also struggle with insecurities about their appearance

Full access

NCCN News

toxicity of immunotherapies.” Immunotherapy-related side effects can occur at any time and can affect any organ. The most common side effects are rash, diarrhea, low thyroid hormone, and fatigue, but they can also include inflammation of the lung

Full access

Patient Case Studies and Panel Discussion: Leukemia – Rare and Emerging Subtypes

are very few treatment options available.” Patient Case Study 2 A 28-year-old woman presented with fatigue and lymphadenopathy. Her initial WBC count was 11.1 k/uL with 40% blasts, and she showed hypercellular bone marrow. Her immunophenotype included

Full access

NCCN News

for related conditions like nausea, fatigue, distress, or immunotherapy-related toxicities. “The Abramson Cancer Center is a perfect fit and wonderful addition to the group of leading cancer centers that comprise NCCN,” said Robert W. Carlson, MD